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Human campylobacteriosis is considered one of the most common foodborne diseases
worldwide with poultry identified as the main source of infection accounting for 50–
80% of human cases. Highly virulent Campylobacter spp., positive for the Type VI
secretion system (T6SS), which have an increased ability to adhere to and invade
the host gastrointestinal epithelium are highly prevalent in poultry. Multidrug resistant
strains of bacteria are rapidly evolving and therefore, new antimicrobials to supplement
animal feed that are able to control Campylobacter species, are in great need. The
work presented herein indicates that a novel phenolic antimicrobial, Auranta 3001, is
able to reduce the adhesion and invasion of human intestinal epithelial cells (HCT-
8) by two T6SS positive chicken isolates, C. jejuni RC039 (p < 0.05) and C. coli
RC013 (p < 0.001). Exposure of C. jejuni RC039 and C. coli RC013 to Auranta 3001
downregulated the expression of hcp and cetB genes, known to be important in the
functionality of T6SS. Furthermore, the reduced adhesion and invasion is associated
with a significant decrease in bacterial motility of both isolates (p < 0.05–p < 0.001)
in vitro. Most importantly our in vivo results show that Auranta 3001 is able to reduce
cecum colonization levels from log 8 CFU/ml to log 2 CFU/ml for C. jejuni RC039
and from log 7 CFU/ml to log 2 CFU/ml for C. coli RC013. In conclusion, this novel
antimicrobial is able to reduce the pathogenic properties of T6SS campylobacters in vitro
and also to decrease colonization in vivo.
Keywords: Campylobacter jejuni, Campylobacter coli, HCT-8, attachment, invasion, gene expression
INTRODUCTION
The Gram-negative pathogen Campylobacter spp. is the most frequent cause of bacterial foodborne
disease (EFSA and ECDC, 2017). The bacterium naturally colonizes the avian intestinal tract, where
it can persist for the entire lifespan of the birds leading to contamination of poultry carcasses
during slaughter, which increases the risk of human exposure to the pathogen (Shortt et al., 2016).
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Campylobacter species can cause gastro-intestinal disorders in
humans, including fever, nausea, and abdominal pain. In a small
group of patients, it can lead to more severe consequences such
as Guillain-Barré syndrome, an acute flaccid paralysis, reactive
arthritis, and inflammatory bowel disease (Chaisowwong et al.,
2012; van Alphen et al., 2012; Hoseinpour et al., 2017).
In order to cause disease Campylobacter interacts with
the gastrointestinal epithelium and colonizes the host. The
full picture of the mechanisms involved is not yet known
(Freitag et al., 2017), but initial progress has been made to
elucidate these mechanisms (Young et al., 2007). Blocking
these initial stages of infection including adhesion, motility,
and chemotaxis is essential as they represent key factors
for a successful infection (Morooka et al., 1985; Nachamkin
et al., 1993; Yao et al., 1997; Hendrixson and DiRita, 2004;
Backert and Hofreuter, 2013). More specifically these virulence
factors include motility systems (flaA and flaB), adhesion
to fibronectin F (cadF), chemotaxis (cetB), invasion proteins,
and cytolethal distending toxins (cdtB), whose production
causes progressive cellular distension and cell death leading to
enteritis. Therefore, reducing the attachment and invasion of
Campylobacter sp. on intestinal epithelial cells and reducing
production of virulence factors such as adhesins and decreasing
motility could potentially control campylobacteriosis. Besides
other virulence factors, capsular polysaccharides contribute to
antimicrobial resistance (Hendrixson et al., 2001; Guerry et al.,
2012).
Treating Campylobacter infections in humans with antibiotics
(e.g., erythromycin, clarithromycin, ciprofloxacin, levofloxacin,
moxifloxacin) is common practice. The increasing resistance of
bacteria to conventional chemicals and drugs, the decline in new
antibiotic discovery over the last few decades, as well as consumer
demands for natural food preservatives have encouraged research
for the identification of novel natural antimicrobials (Kovac et al.,
2015; Oh and Jeon, 2015a; Stratakos et al., 2018). Plant extracts
have been used for decades not only as flavor enhancers, but
also to extend the shelf life and microbiological safety of food
(Hintz et al., 2015). Their applicability was also proven for the
treatment of a range of human and animal diseases, improving
human health (Holley and Patel, 2005; Teichmann et al., 2016).
Controlling Campylobacter spp. is considered a public health
priority. Antimicrobial products are used in general with
the aim of bacterial killing but this may have a damaging
effect on the host microbiome. Therefore, investigations
into the possibility of achieving a reduced virulence rather
than a lethal effect would be of interest. Auranta 3001
has been shown to be involved in reduced virulence of
Cryptosporidium hominis and Cryptosporidium parvum by
downregulating CpSUB1 gene expression (Stratakos et al.,
2017). In order to avoid any effect on bacterial survival
and growth, and therefore apply less selective pressure for
the development of resistance, sub-inhibitory concentrations
of antimicrobials need to be identified. The use of sub-
inhibitory concentrations is necessary for the sound investigation
of the anti-virulence capacity of antimicrobials/compounds
(Kummerer, 2004). Our study aimed to investigate if sub-
inhibitory concentrations of a mixture of organic acids and
plant extracts (Auranta 3001) can reduce the virulence of T6SS
positive C. jejuni and C. coli isolates in human HCT-8 cell
models and colonization of caeca in artificially infected chicken
broilers.
MATERIALS AND METHODS
Strains and Culture Conditions
C. jejuni RC039 and C. coli RC013 strains were obtained from
the AFBI laboratory collection and were grown on Blood Agar
Base No. 2 (Oxoid Ltd., United Kingdom) supplemented with 5%
(vol/vol) defibrinated horse blood (Aquilant Scientific N.I.). The
strains were grown under microaerophilic conditions at 41.5◦C
in 85% N2, 5% O2, and 10% CO2 in a Don Whitley MACS-
VA500 microaerophilic workstation (Davidson & Hardy Ltd.,
United Kingdom) for 48 h. To enumerate viable microorganisms,
suitable 10-fold dilutions were made in Maximum Recovery
Diluent (Oxoid Ltd., United Kingdom). One hundred microliters
of each of the 10-fold dilutions were spread on Campylobacter
Blood-Free Selective Agar Base (Modified CCDA – Preston;
Oxoid Ltd., United Kingdom) without any supplement, and
plates were incubated under microaerophilic conditions at
41.5◦C for 48 h.
Chemicals
The novel antimicrobial (Auranta 3001) was supplied by
Auranta – Envirotech Innovative Products Ltd and contains lactic
and citric acid. The antimicrobial also contains: glycerine-based
emulsifying agent, sodium chloride, sodium hydroxide, citrus
extract (6%), oregano extract (1%), grape seed extract (2%).
Infection
The ECACC human ileocecal adenocarcinoma cells (HCT-8)
were grown in RPMI 1640 (Lonza, Analab Ltd., United Kingdom)
supplemented with 10% fetal bovine serum and 2 mL glutamine.
The cells were routinely grown in 75 cm2 tissue culture flasks
(Sigma-Aldrich, Arklow, Ireland, SIAL0641) in a humidified
incubator at 37◦C with 5% CO2. The gentamicin protection assay
was used to test the role of Auranta 3001 in the ability of C. jejuni
RC039 and C. coli RC013 to adhere to and invade host epithelial
cells as previously described (Corcionivoschi et al., 2009). HCT-
8 cells were grown (80–90% confluence) for 22 to 24 h in
six-well tissue culture plates at a concentration of 5.5 × 105
cells per well. For some experiments, HCT-8 monolayers were
preincubated with 0.1 and 0.5% Auranta 3001 for 1–3 h. Plate
grown C. jejuni RC039 and C. coli RC013 were harvested, washed,
and re-suspended in tissue culture medium at an OD600 of 0.3
and 0.25, respectively. The bacterial isolates were preincubated
for 1–3 h in the presence of 0.1 and 0.5% Auranta 3001. The
HCT-8 cells were washed with fresh culture media containing
10% FBS, and 2 ml of fresh culture medium was added to each
well. Bacteria were added to give a multiplicity of infection
of 100. Tissue culture plates were centrifuged at 250 × g for
5 min and incubated for 3 h at 41.5◦C in 85% N2, 5% O2, and
10% CO2. To quantify the number of cell-associated bacteria,
infected monolayers were washed three times with PBS and
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treated with 0.1% Triton X-100 in PBS at 41.5◦C for 15 min.
Tenfold dilutions of each well were plated onto CCDA agar and
colonies enumerated after 2 days of incubation at 41.5◦C in 85%
N2, 5% O2, and 10% CO2. To quantify the number of bacteria
that invaded HCT-8 cells, the infected monolayers were washed
with tissue culture medium. Fresh medium (2 ml) containing
gentamicin (400 µg/ml) was added to kill bacteria that were not
internalized. Medium without gentamicin was added to quantify
the number of bacteria that adhered to the epithelial cells. The
tissue culture plates were then incubated for a further 3 h at
41.5◦C and washed with fresh RPMI 1650 + 10% FBS. HCT-8
cells were lysed by the addition of 1 ml of 0.1% Triton X-100
in PBS and incubated for 15 min at 41.5◦C (Corcionivoschi
et al., 2009). Because in our study, we have used chicken isolates
the incubation temperature was increased from 37 to 41.5◦C.
Tenfold dilution of the contents of each well was plated onto
CCDA agar, and colonies were enumerated after 2 days of
incubation. Invasion efficiency was calculated as the percentage
of the total number of CFU/total initial inoculum. All assays were
conducted in triplicate and repeated independently three times.
The significance of differences in adhesion and invasion between
samples was determined using the Student’s t-test. A P-value of
<0.05 was defined as significant.
Susceptibility to Auranta 3001
The twofold tube dilution method was used to determine the
lowest concentration of Auranta 3001 that can inhibit growth
of bacteria (MIC) and the lowest concentration that results in
bacterial death (MBC) according to Zhu et al. (2016). Auranta
3001 was diluted (8% down to 0.0078% v/v) in Müeller Hinton
broth (MHB) and thoroughly vortexed. Individual overnight
bacterial cultures were harvested by centrifugation, washed with
PBS, and diluted to approximately 1 × 106 CFU/mL in MHB.
Each tube was inoculated with approximately 5 × 105 CFU/mL
of this bacterial culture (final concentration). Noninoculated
tubes containing the same growth medium were used as negative
controls and tubes inoculated with individual bacterial cultures
in MHB without Auranta 3001 were used as positive controls.
Subsequently, the tubes were incubated at 41.5◦C for 48 h. Tubes
without visible growth were considered as below the MIC. One
hundred milliliters were taken from the tubes that showed no
growth and inoculated onto MHA plates, the highest dilution
with no microbial growth was considered as the MBC. Each assay
was repeated three times for each strain. In order to determine
the sub-inhibitory concentrations used, the two pathogens were
exposed to different concentrations of the antimicrobial. The
concentrations that showed no effect on survival and no growth
inhibition (same growth kinetics as the control) were used for the
subsequent experiments.
Motility Assay
The motility of C. jejuni RC039 and C. coli RC013 was measured
after the two strains were exposed to Auranta 3001 for 1, 2, and
3 h at a concentration of 0.1 and 0.5%. In short, 5 µl of culture
(grown on blood agar for 48 h and recovered in 1 ml brain
heart infusion – BHI – broth) was inoculated into the center
of a 20 ml semi-solid BHI plate (0.4% agar). The radius of the
zone of visible growth was measured after 48 h of incubation
under microaerophilic conditions at 41.5◦C. The experiment was
carried out in triplicate, on three different days. The results are
expressed as percentage decrease compared to the control.
Capsule Polysaccharide (CPS) Detection
Capsule polysaccharide was prepared from bacteria co-cultured
with HCT-8 cells which were pretreated with Auranta 3001
and from bacteria directly exposed to Auranta 3001 following a
previously described protocol (Hitchcock, 1983). Bacteria were
harvested by centrifugation and suspended in 100 µl of lysis
buffer containing 31.25 mM Tris-HCl (pH 6.8), 4% sodium
dodecyl sulfate, 0.025% bromophenol blue, and 20% glycerol.
After heating to 100◦C for 5 min, 5 µl of 20 mg/ml proteinase
K was added to the solution, and the tubes were incubated
for 1 h at 50◦C. The samples were separated on NuPageNovex
12% bis-Tris gels (Invitrogen, United Kingdom). Following
electrophoresis, gels were stained with an Alcian blue (Sigma
Aldrich, United Kingdom) solution containing 0.1% Alcian blue,
40% ethanol, and 5% acetic acid (Karlyshev and Wren, 2001).
RNA Extraction and qRT-PCR
Total RNA was isolated from bacteria exposed to Auranta 3001
at a concentration of 0.1 and 0.5% for 1, 2, and 3 h by using
the RNeasy R©Plus Mini Kit (Qiagen, United Kingdom). The
RNA was reverse transcribed using Transcriptor First Strand
cDNA Synthesis Kit (Roche, United Kingdom) according to the
manufacturer’s protocol. The mRNA levels were determined
by quantitative RT-PCR using QuantiNovaSYBR R© Green
PCR Kit (Qiagen, United Kingdom) on a LightCycler R© 96
(Roche, United Kingdom). The primers used (Invitrogen,
United Kingdom) are described in Table 1, and the conditions
for genes rRNA 16S consisted of incubating for 10 min at 95◦C
followed by 45 cycles of 95◦C for 10 s, 55◦C for 30 s, and 72◦C for
10 s. A total of 5 µl of SYBR Green master mixture was used in
each reaction along with 0.5 µl of 10 µM primer mixture, 3 µl of
molecular grade water, and 1 µl of DNA sample. For cetB (10 min
at 95◦C, followed by 45 cycles of 95◦C for 10 s, 54◦C for 20 s, and
a final extension at 72◦C for 5 min) a total of 5 µl of SYBR Green
master mixture was used in each reaction along with 1.4 µl of
20 µM primer mixture, 5.2 µl of molecular grade water, and 2 µl
of DNA sample. For hcp (2 min at 95◦C, followed by 40 cycles
TABLE 1 | List of primer sequences used for qRT-PCR for C. jejuni RC039 and C. coli RC013 genes associated with virulence.
Gene Primer sequence – forward Primer sequence – reverse Reference
cetB 5′ GCCTTGTTGCTGTTCTGCTC 3′ 5′ TTCCGTTCGTCGTATGCCAA 3′ Upadhyay et al., 2017
hcp 5′ CAAGCGGTGCATCTACTCAA 3′ 5′ TAAGCTTTGCCCTCTCTCCA 3′ Harrison et al., 2014
rRNA 16S 5′ ATCTAATGGCTTAACCATTAAAC 3′ 5′ GGACGGTAACTAGTTTAGTATT 3′ Douglas Inglis and Kalischuk, 2003
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TABLE 2 | Chemical composition of basal diet.
Item Starter Grower Finisher
0–10 days 11–24 days 25–35 days
Wheat 54.623 57.553 61.300
Full fat soya 12.000 12.000 12.000
Brazilian GM hipro 25.000 21.000 17.000
Lime bulk 0.717 0.700 0.500
DCP bulk (18.1% p) 1.654 2.000 2.150
Salt bulk 0.200 0.200 0.200
Sod.bi-carbonate 0.199 0.166 0.162
DL methionine 0.487 0.435 0.378
L-lysine 0.373 0.318 0.281
Threonine 0.247 0.128 0.029
Vitamin+mineral premix 0.500 0.500 0.500
Soyabean oil 4.000 5.000 5.500
Calculated composition (%)
ME Kcal/kg 2999 3081 3133.8
CP 23.12 21.53 20.04
Lys 1.45 1.308 1.17
Met+Cys 1.089 0.996 0.91
Ca 0.97 0.906 0.85
AvP 0.49 0.41 0.409
of 95◦C for 5 s, 60◦C for 10 s, and a final extension at 72◦C for
5 min), a total of 5 µl of SYBR Green master mixture was used in
each reaction along with 0.8 µl of 20 µM primer mixture, 7.4 µl
of molecular grade water, and 1 µl of DNA sample. Relative
quantity of the mRNA was calculated using the 1Ct method.
rARN 16S gene was used as an endogenous control since it was
transcribed in equal rates in both treated and untreated cells.
In vivo Infection Assay
Twenty male chicken broilers (Ross 308) were housed in
isolation units on wood shaving bedding. The temperature in the
isolation unit was kept between 22 and 25◦C and thermostatically
controlled. Broilers were fed ad libitum with a standard diet as
described in Table 2. C. jejuni RC039 and C. coli RC013 were
grown as described above and suspended in sterile distilled water
at a concentration of 1 × 107 CFU/ml. At the age of 15 days, 10
broilers were inoculated with 0.1 ml of C. jejuni RC039 and the
other 10 broilers with 0.1 ml C. coli RC013. The infected broilers
were kept in separated and sterile isolation units. Five chickens
from each infected group received for 3 days, ad libitum, water
containing 0.5% Auranta 3001 with the remaining ones receiving
water only. After 3 days of treatment, broilers were euthanized,
and Campylobacter was enumerated by analyzing the cecum
content. All broilers were confirmed as being Campylobacter free
at the time of infection, using cloacal swabs. These experiments
were performed in triplicate on three separate occasions. The
experiments were performed according to the legislation in place
(Law 471/2002 and government ordinance 437/2002) and under
the supervision of National Sanitary Veterinary Agency. The
ethics committee of Banat University of Agricultural Sciences and
Veterinary Medicine – King Michael I of Romania, approved this
work
TABLE 3 | Minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) activity of the Auranta 3001.
Strains Origin MIC MBC
Campylobacter jejuni RC039 poultry 1% 1%
Campylobacter coli RC013 poultry 2% 2%
The antimicrobial was tested at concentrations from 8 to 0.0078% (v/v) in three
independent experiments.
Transepithelial Resistance of Cellular
Tight Junctions (TEER)
Transepithelial resistance measures the integrity of cellular
tight junctions and is a suitable method to be used in cell
culture monolayers for the purpose of measuring the effect of
bacteria during infection in vitro (Srinivasan et al., 2015). This
methodology measures the electrical resistance, in ohms, as a
measure of cellular barrier integrity. For the purpose of TEER
measurement, the HCT-8 cells were grown on 0.4 µm and 12 mm
pore size transwell inserts (Corning) and selected based on the
formation of a confluent monolayer. Our aim was to investigate
the effect of Auranta 3001 on the barrier properties of HCT-8
cells by taking TEER measurements at 3 h postinfection (±0.1
and 0.5% Auranta 3001) using an EVOM X meter connected to
an Endohm chamber (World Precision Instruments).
Statistical Analysis
All experiments were performed in triplicate and data presented
as mean ± SEM. To measure the statistical significance of the
infection assays and gene expressions results, we used two tailed
Student’s t-test. A group difference was assumed to be statistically
significant when P? < ?0.05. All results were expressed as
means± SD.
RESULTS
Identification of the Sub-Inhibitory
Concentrations
In order to investigate if the antimicrobial agent has any effect
in reducing pathogenicity, by attenuating bacterial virulence
factors, we first had to identify the sub-inhibitory concentrations
for both isolates (C. jejuni RC039 and C. coli RC013). Strong
antimicrobial activities against both C. jejuni RC039 and C. coli
RC013 were observed. The minimum inhibitory concentrations
were 1% for C. jejuni RC039 and 2% for C. coli RC013, and
minimum bactericidal concentrations were recorded at similar
concentrations (Table 3). We have concluded that concentrations
of 0.1 and 0.5% were most appropriate for our next investigations
in order to avoid any antimicrobial killing or any effect on
bacterial growth
Auranta 3001 Reduces the Motility of
C. jejuni RC039 and C. coli RC013
Having identified the sub-inhibitory concentrations, we have
next studied the potential impact on virulence by the reduction
of bacterial motility (Figure 1). Motility plate assays showed
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FIGURE 1 | The effect of Auranta 3001 on C. jejuni RC039 and C. coli RC013 motility. (A) shows the percentage decrease of C. jejuni RC039 motility and (B) of
C. coli RC013 over control. Asterisks indicate significant differences (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). Error bars represent the standard deviation of means
from three different experiments, each containing triplicate samples.
FIGURE 2 | Adhesion and invasion of HCT-8 cells by C. jejuni RC039. The adherence (A) and invasion (B) of HCT-8 cells in the presence of Auranta 3001. Results
are expressed as percentages of the initial inoculum. Asterisks indicate significant differences (Student’s t-test ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). Error bars
represent the standard deviation of means from three different experiments, each containing triplicate samples.
that both strains were highly motile but the pretreatment with
0.1 and 0.5% Auranta 3001 significantly reduced motility in a
dose and time dependent manner. As reflected in Figures 1A,B,
a concentration of 0.1% Auranta 3001 significantly reduced
motility after only 2 h for both C. jejuni RC039 (p < 0.01) and
C. coli RC013 (p < 0.05). A concentration of 0.5% Auranta 3001
reduced bacterial motility by more than 20% (p < 0.001) after
1, 2, and 3 h for C. jejuni RC039 (Figure 1A), and for C. coli
RC013 (Figure 1B) when compared to the control. These results
suggested that this antimicrobial can have a negative impact on
the motility of C. jejuni and C. coli T6SS positive isolates.
Auranta 3001 Reduces C. jejuni RC039
and C. coli RC013 Virulence in vitro and
Decreases Colonization in vivo
To demonstrate if the negative effect observed on motility also
translates to reduced virulence we performed in vitro infection
assays as described in Materials and Methods section. The
presence of Auranta 3001 in the culture media throughout the
infection assay significantly reduced the adherence of C. jejuni
RC039 to HCT-8 cells (Figure 2A) at a concentration of 0.5%,
while the negative effect on invasion (Figure 2B) was significant
at both concentrations (p < 0.001). In the case of C. coli RC013,
the negative effect on adherence (Figure 3A) and invasion
(Figure 3B) was significant (p < 0.001) at both 0.1 and 0.5%
Auranta 3001. The invasion ability of C. jejuni RC039 and
C. coli RC013 was significantly diminished (p < 0.001) when
HCT-8 cells only were exposed to Auranta 3001 suggesting that
host related infection pathways are affected by the pretreatment
(Supplementary Figure 1). Moreover, if the bacteria only are
pretreated, prior to infection their invasion capacity is also
dramatically reduced (Supplementary Figure 2). Overall, these
data indicate that the reduced infection could be due to
biological changes in both the host and the bacterium. The
successful reduction in virulence obtained in vitro was extremely
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FIGURE 3 | Adhesion and invasion of HCT-8 cells by C. coli RC013. The adherence (A) and invasion (B) of HCT-8 cells in the presence of Auranta 3001. Results are
expressed as percentages of the initial inoculum. Asterisks indicate significant differences (Student’s t-test ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). Error bars
represent the standard deviation of means from three different experiments, each containing triplicate samples.
encouraging and as a consequence we then investigated the effect
of Auranta 3001 in preventing cecum colonization of artificially
infected chicken broilers. In vivo, quantification of viable bacteria
in cecum content showed significant decrease (p < 0.05) in the
ability of Campylobacter to colonize the gastrointestinal tract.
For C. jejuni RC039, the decrease was from log 8 CFU/ml to 2
log CFU/ml and for C. coli RC013 from 7 log CFU/ml to 2 log
CFU/ml (Table 4). In conclusion, the addition of Auranta 3001
to the drinking water significantly reduced the ability of C. jejuni
RC039 and C. coli RC013 to colonize the broiler cecum when
compared to controls.
Changes in Capsule Polysaccharide
(CPS) Profiles of C. jejuni RC039 and
C. coli RC013 Following Exposure to
Auranta 3001
Having observed that exposure of bacteria to the antimicrobial
reduces their virulence we then investigated the production
of CPS, a major virulence and colonization factor in
campylobacters. Our results show that exposure of HCT-8
cells to 0.1% Auranta 3001 prior to infection leads to a significant
decrease in the amounts of CPS detected on co-cultured
TABLE 4 | Detection of viable campylobacters (log10 CFU/ml).
Experiment C. jejuni RC039 C. coli RC013
+A3001 −A3001 +A3001 −A3001
A 3.9 × 102a 7.3 × 108 4.2 × 102a 5.1 × 106
B 2.7 × 102a 8.1 × 109 2.7 × 103a 3.3 × 107
C 1.2 × 102a 6.6 × 108 3.9 × 102a 4.7 × 106
aSignificantly (P < 0.05) less than the untreated control.
A, B, and C represent three replicate experiments performed in three separate
occasions.
C. jejuni RC039 (Figure 4A, lanes 3 and 5) compared to control.
Interestingly a similar effect was not detected for C. coli RC013
in which case no difference was observed when compared to
control (Figure 4B).
Auranta 3001 Downregulates hcp and
cetB Gene Expression in C. jejuni RC039
and C. coli RC013
The effect of Auranta 3001 on the expression of C. jejuni RC039
and C. coli RC013 hcp gene is shown in Figure 5. The qRT-
PCR results revealed that the antimicrobial agent reduced the
transcription levels of hcp and the energy chemotaxis related
gene (cetB). Exposure of C. jejuni RC039 to 0.1% Auranta
3001 (Figure 5A) resulted in a fivefold reduction of hcp gene
expression with a 10-fold reduction in C. coli RC013 (p < 0.01).
Interestingly only twofold downregulation of the hcp gene
(Figure 5A) was observed when both isolates were exposed to
0.5% Auranta 3001. In the case of cetB gene expression in C. jejuni
RC039, we show a significant marked increase (p < 0.01) in
downregulation following exposure from fivefold at 0.1% to 10-
fold at 0.5% (Figure 5B). For C. coli RC013, the downregulation
of cetB was more significant following exposure to 0.1% Auranta
3001 compared to 0.5% (p< 0.05).
Auranta 3001 Prevents Tight Junction
Disruption During Infection
As shown in Figures 2, 3 Auranta 3001 reduces the virulence
of both C. jejuni RC039 and C. coli RC013 when used at
concentrations between 0.1 and 0.5%. We have hypothesized
that the effect could be caused by an increase in tight junction
resistance. In order to test our hypothesis, TEER was measured
at 3 h postinfection in the presence of 0.1 and 0.5% Auranta
3001. By 3 h postinfection, there was a significant increase
(p < 0.01) in TEER in both uninfected and infected cells when
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FIGURE 4 | Alcian blue profiles of Campylobacter jejuni RC039 (A) and Campylobacter coli RC013 (B) capsule polysaccharides when co-cultured with HCT-8 cells
pretreated with 0.1% Auranta 3001.
FIGURE 5 | Effect of Auranta 3001 on C. jejuni RC039 and C. coli RC013 cetB (B) and hcp gene (A) expression after 3 h of exposure to 0.1 and 0.5% Auranta
3001. Asterisks indicate significant differences (Student’s t-test ∗p < 0.05; ∗∗p < 0.01). Error bars represent the standard deviation of means from three different
experiments.
Auranta 3001 was present in the infection media (Figure 6). The
results were similar when 0.1% Auranta 3001 was used (data
not shown). These results indicate that Auranta 3001 inhibits
the disruption of the tight junctions during infection preventing
pathogen translocation and subsequent infection.
DISCUSSION
Campylobacter remains an important microbiological
contaminant of chicken products despite substantial efforts
to reduce the infection (Hermans et al., 2011a). An effective
preharvest control strategy that reduces pathogen colonization in
the cecal environment could reduce the risk of fecal shedding and
therefore product contamination considering that Campylobacter
resides primarily in the cecal crypts of birds (Beery et al., 1988).
Administration of antimicrobial treatment through feed can
be applied as a practical method for controlling pathogen
colonization. Plant-derived compounds or phytochemicals
represent a large unexploited resource that can serve as a safe
and effective alternative for controlling pathogens in birds,
considering that there is an increasing number of customers that
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FIGURE 6 | Transepithelial resistance of HCT-8 cells infected with C. jejuni
RC039 and C. coli RC013 at 3 h postinfection using 0.5% Auranta during
infection. Asterisk indicates significant difference (∗∗P < 0.001) compared to
uninfected cells. Error bars indicate standard deviations.
demand antibiotic free chickens. In addition, in the EU the use
of antibiotics as growth promotors is not permitted (Hermans
et al., 2011b; Wagle et al., 2017).
Bacterial virulence factors such as adhesion are important
for colonization; a reduction in this particular attribute could
minimize Campylobacter ability to attach to the epithelial cells,
hence its colonization of poultry (Jin et al., 2001; Hermans
et al., 2011a). Previously, Byrne et al. (2007) showed that
Campylobacter spp. attaches and invades both primary chicken
enterocytes and human epithelial cells with similar efficiency. The
effect of other natural antimicrobials has been widely investigated
in different studies of Campylobacter spp. infection. Blackberry
(Rubus fruticosus) and blueberry (Vaccinium corymbosum)
extracts have been shown to significantly reduce the adhesion and
invasion to epithelial cells (Salaheen et al., 2014). Other extracts
from Artemisia ludoviciana, Acacia farnesiana, Cynarascolymu
ssp., Opuntiaficus indica (Castillo et al., 2014), as well as
β-resorcylic acid, have shown similar effects (Wagle et al.,
2017). During the course of this study, we have explored the
efficacy of Auranta 3001 (a mixture of organic acids and plant
extracts) in reducing the ability of C. jejuni and C. coli, T6SS
positive isolates, to invade epithelial cells in vitro. Our results
indicate that the antimicrobial agent has a direct effect on the
pathogen as following pretreatment of C. jejuni RC039 and C. coli
RC013 a statistically significant reduction in invasiveness was
observed (p < 0.001). This effect was slightly more pronounced,
compared to control, with the increased exposure time and the
concentration of Auranta 3001. Moreover, we have observed
similar results when Auranta 3001 was used to pretreat the HCT-
8 cells before infection, suggesting that the antimicrobial agent
may potentially interfere with the host cell metabolic pathways,
which subsequently affect the ability of bacteria to infect. This
theory is supported by a study, which indicates that carvacrol, the
main component of oregano, does not inhibit bacterial growth
but significantly reduces the virulence potential of C. jejuni and
protects against cellular infection of INT-407 cells (van Alphen
et al., 2012). Similarly, Citral, which is found in citrus extracts,
is able to significantly suppress the attachment and invasion to
Caco-2 cells and inhibit the expression of genes involved in the
attachment and invasion of host cells by C. sakazakii (Shi et al.,
2017).
Cellular tight junctions are a physical barrier against pathogen
intrusion and strengthening them is key in the development of
novel strategies against Campylobacter spp., infection (Hatayama
et al., 2018). Campylobacter ability to disrupt the tight junctions
and invade via the basolateral site of eukaryotic cells has been
reported in several studies (Monteville and Konkel, 2002; Chen
et al., 2006). The increase in TEER, observed in our studies,
suggests that the tight junctions of infected cells are strengthened
in the presence of Auranta 3001, which could have contributed to
the reduction in adhesion and invasion of the two isolates.
To investigate the potential mechanism of action of Auranta
3001, we evaluated the effect of the antimicrobial on various
virulence attributes of C. jejuni and C. coli. Motility is crucial
to Campylobacter pathogenesis both in vitro and in vivo, and
it has been shown that diminished motility results in reduced
ability to invade epithelial cells in vitro (Yao et al., 1994; Golden
and Acheson, 2002; Stahl et al., 2014). Our study shows that
the antimicrobial agent significantly reduces the motility of
C. jejuni RC039 and C. coli RC013 in a time and dose-dependent
manner. Similar results were reported in a recent study, which
describes that preexposure of Campylobacter spp. to different
concentrations of organic oils, such as carvacrol, eugenol, and
thyme reduced the motility and invasion of C. jejuni into
intestinal epithelial cells, without affecting the normal function
of the cells (Upadhyay et al., 2017). A citric-based disinfectant
applied at sub-inhibitory concentrations reduced the motility
of Campylobacter jejuni as well as interfered with quorum-
sensing activity and biofilm formation (Castillo et al., 2015).
A similar effect was observed when lactic acid was applied at a
concentration of 0.6% in Salmonella typhimurium (Burt et al.,
2016). Mith et al. (2015) also found that oregano essential oil and
carvacrol are able to significantly down-regulate genes involved
in motility of E. coli O157:H7 (Mith et al., 2015). Therefore, since
the antimicrobial is a mixture of organic acids and plant extracts
(e.g., oregano), it is likely that the reduced motility observed in
C. jejuni and C. coli is a result of the down-regulation of genes
involved in motility.
Motility is an important virulence factor in Campylobacter
jejuni (Corcionivoschi et al., 2012) that can be affected by
structural and quantitative changes in surface polysaccharides
(CPS). These changes are very important because similar to
other bacterial pathogens, Campylobacter spp. expresses capsular
polysaccharides as a virulence factor to avoid opsonophagocytosis
(Nanra et al., 2013). CPS was also previously shown to play an
important role in systemic infections as well as in induction of
ovine abortion due to antigenic variation and immune evasion
(Sahin et al., 2017). Interestingly, our study shows that changes
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were only detected for C. jejuni RC039 CPS profiles but absent in
C. coli RC013. This is possibly caused by the significant diversity
in gene content between C. jejuni and C. coli (Dorrell et al., 2001).
These variations for both CPS and LOS could be reflected in
variable effects on the bacterial virulence potential.
At gene expression level, it was described previously that
sub-inhibitory concentrations of antimicrobials influences gene
transcription levels in many bacterial pathogens (Tsui et al.,
2004; Donoghue et al., 2015; Oh and Jeon, 2015b). Since
the sub-inhibitory concentrations of Auranta 3001 did not
inhibit the growth of C. jejuni RC039 and C. coli RC013, the
reduction, observed in the virulence attributes, could be due
to the effect of the antimicrobial on the transcription of the
virulence genes. Therefore, we used qRT-PCR to determine
the effect of Auranta 3001 on the expression of cetB and hcp
genes of Campylobacter. CetB is involved in energy chemotaxis
and has been described to play a role in motility (Konkel
et al., 1997; Reuter et al., 2010; Hermans et al., 2011a).
The hcp gene encodes for a hemolysin-correlated protein
and is a key indicator for a functional T6SS (Corcionivoschi
et al., 2015; Ugarte-Ruiz et al., 2015). It has been shown
that inactivation of C. jejuni T6SS resulted in a reduction of
adherence to and invasion of in vitro cell lines, while over-
expression of a hemolysin co-regulated protein (hcp), greatly
enhanced these processes (Lertpiriyapong et al., 2012). During
our study, we observed that Auranta 3001 modulated the
transcription level of genes coding energy chemotaxis (cetB) and
hemolysin correlated protein (hcp) thus indicating that the anti-
Campylobacter colonization effect observed with Auranta 3001
could be mediated via down-regulation of critical colonization
genes.
Chicken broilers are still the main source of Campylobacter-
related infections. Development of novel strategies and products
that could be efficient in reducing the colonization levels
in poultry is currently becoming a priority for the industry
(Johnson et al., 2017). Our in vivo results indicate a reduction
in colonization up to 6 logs between treated and untreated
groups. These results clearly show that the anti-pathogenic
effect of Auranta 3001, observed in vitro, also translates in less
colonization in vivo. In conclusion, our results indicate that
Auranta 3001 is able to significantly reduce the invasiveness of
C. jejuni and C. coli and protect the host cells in vitro and
in vivo against Campylobacter infection and colonization. This
effect is expressed by its negative impact on important virulence
factors such as motility, adherence, and internalization. Based on
these results, Auranta 3001 shows great potential as a method
to control campylobacteriosis and provides more information in
regards to the mechanistic mode of action of novel antimicrobial
products and extracts. Further in vivo studies could potentially
explain the mechanism of action, by characterizing the genomic,
transcriptomic, and proteomic profiles of the pathogens.
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